Vanda Pharmaceuticals Shares Latest Update on VQW-765 Drug Development Status #United_States #Washington #Clinical_Trial #Vanda_Pharmaceuticals #VQW-765

Vanda Pharmaceuticals Shares Latest Update on VQW-765 Drug Development Status #United_States #Washington #Clinical_Trial #Vanda_Pharmaceuticals #VQW-765
Vanda Pharmaceuticals to Showcase Groundbreaking Research at 2026 EADV Annual Meeting #United_States #Washington #Vanda_Pharmaceuticals #Imsidolimab #EADV
Vanda Pharmaceuticals Reports Encouraging Phase III Findings for HETLIOZ® in Treating Delayed Sleep-Wake Phase Disorder #United_States #Washington #Vanda_Pharmaceuticals #Hetlioz #DSWPD